![]() |
F.D.A. Wants More Tests on a Novo Nordisk Insulin, Tresiba
The request by the F.D.A. for more data on the heart risks of a diabetes drug will delay an important product for Novo Nordisk of Denmark.
![]() More... |
| All times are GMT. The time now is 12:51 AM. |